Clinical Trial Update: Safety, Preliminary Pharmacokinetics and Bronchodilator Properties of V0162 [Phase 1, Phase 2]

View source ↗

Summary

This trial update reports safety, preliminary pharmacokinetics, and bronchodilator properties of V0162 in Phase 1/2 for chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• V0162

Snippet

Sponsor: Pierre Fabre Medicament | Conditions: Chronic Obstructive Pulmonary Disease | Phase 1, Phase 2 | Status: COMPLETED